Cupat, Erlinda G.

HRN: 21-28-55  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2022
CEFTRIAXONE 1G (VIAL)
04/27/2022
05/04/2022
IVT
2g
Q24
CAP
Waiting Final Action 
04/27/2022
AZITHROMYCIN 500MG TABLET (TAB)
04/27/2022
05/01/2022
ORAL
500mg
Q24
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: